Symprove bacteria

Symprove is considered to have the highest quality strains of any probiotic by gastroenterologists.3 Symprove contains four live strains of bacteria:†

Lactobacillus acidophilus

NCIMB 30175

Lactiplantibacillus plantarum

NCIMB 30173

Lacticaseibacillus rhamnosus 

NCIMB 30174

Enterococcus faecium

NCIMB 30176

Lactiplantibacillus species

  • Various types of these bacteria are found in the human gastrointestinal tract
  • Rhamnosus, acidophilus and plantarum all have a history of being used in food4
  • The European Food Safety Authority has added these three species to the Qualified Presumption of Safety list5

Enterococcus faecium

  • These bacteria are commonly found in human microbiomes and have a history of being used in food6
  • The strain used in Symprove is fully characterised and has been subject to whole genome sequencing by the NCIMB, to confirm identity and provide safety data, which differentiate it from other strains7

1. Fredua-Agyeman M, et al. Benef Microbes 2015;6(1):141–51.

2.  Moens F, et al. Int J Pharm 2019;555:1-10.

3. Data on file, 2024.

4.  Goldstein E, et al. Clin Infect Dis 2015;60(2):S98-S107.

5.  European Food Safety Authority (EFSA). Updated list of QPS-recommended microorganisms for safety risk assessments carried out by EFSA.DOI 10.5281/zenodo.1146566.

6. Gelsomino R, et al. Appl Environ Microbiol 2002;68(7):3560-5.

7. Symprove data on file 2023.

8. Sisson G, et al. Aliment Pharmacol Ther 2014;40(1):51–62.

9. Kvasnovsky CL, et al. Inflammopharmcology 2017; doi: 10.1007/s10787-017-0363-y.

10. Bjarnason I, et al. Inflammopharmacology 2019;27(3):465–73.

*Based on research carried out in 432 healthcare professionals
and independently analysed, 2024.

†Symprove contains four live strains of bacteria: Lacticaseibacillus rhamnosus NCIMB 30174, Enterococcus faecium NCIMB 30176, Lactobacillus acidophilus NCIMB 30175, Lactiplantibacillus plantarum NCIMB 30173. The bacteria in Symprove have all been independently characterised by the NCIMB (The National Collection of Industrial and Marine Bacteria) using the latest DNA sequencing and mass spectrometry techniques. These methods have enabled characterisation of the genera, species and strains.

Symprove delivers 10 billion CFUs (colony-forming units) per 70ml cup, consistent with amount used in human clinical research trials.